Alpha 2.0
Login Register
» Authors » Valentin Boudo

Valentin Boudo

Explore the profile of Valentin Boudo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 196
Followers 0
Related Specialties
Public Health
General Medicine
Tropical Medicine
Top 10 Co-Authors
Ali Sie
Elodie Lebas
Catherine E Oldenburg
Benjamin F Arnold
Clarisse Dah
Mamadou Bountogo
Thomas M Lietman
Mamadou Ouattara
Kieran S OBrien
Till Barnighausen
Published In
Am J Trop Med Hyg
JMIR Mhealth Uhealth
PLOS Glob Public Health
Trials
Front Public Health
Affiliations
Soon will be listed here.
Recent Articles
1.
Perceptions and predictors of COVID-19 vaccine hesitancy among healthcare providers across five countries in sub-Saharan Africa
Madzorera I, Abokyi L, Apraku E, Azemraw T, Boudo V, James C, et al.
PLOS Glob Public Health . 2025 Feb; 5(2):e0003956. PMID: 39982973
The African continent has some of the world's lowest COVID-19 vaccination rates. While the limited availability of vaccines is a contributing factor, COVID-19 vaccine hesitancy among healthcare providers (HCP) is...
2.
Understanding the Risk Factors, Burden, and Interventions for Chronic Respiratory Diseases in Low- and Middle-Income Countries: A Scoping Review
Boutros P, Kassem N, Boudo V, Sie A, Munga S, Maggioni M, et al.
Public Health Rev . 2024 Nov; 45:1607339. PMID: 39544625
Objective: This scoping review aims to identify risk factors for COPD and asthma, examine the burden and intervention measures, and clarify the findings in the context of climate change, with...
3.
Mass azithromycin for prevention of child mortality among children with acute malnutrition: A subgroup analysis of a cluster randomized controlled trial
Sie A, Ouattara M, Bountogo M, Boudo V, Ouedraogo T, Dah C, et al.
PLOS Glob Public Health . 2024 Oct; 4(10):e0003875. PMID: 39466816
Children with acute malnutrition are at high risk of morality. Mass azithromycin distribution reduces all-cause mortality among children aged 1-59 months, and effects may be greater in underweight infants. Here,...
4.
Cause-Specific Mortality among Infants in a Randomized Controlled Trial of Azithromycin Compared to Placebo for Prevention of Mortality
Ouattara M, Sie A, Bountogo M, Boudo V, Ouedraogo T, Dah C, et al.
Am J Trop Med Hyg . 2024 Sep; 111(6):1353-1355. PMID: 39317182
Although community randomized trials have found a reduction in all-cause child mortality in communities receiving mass azithromycin distribution compared with placebo, individually randomized trials have not found similar protective effects....
5.
Mass Azithromycin Distribution to Prevent Child Mortality in Burkina Faso: The CHAT Randomized Clinical Trial
Oldenburg C, Ouattara M, Bountogo M, Boudo V, Ouedraogo T, Compaore G, et al.
JAMA . 2024 Feb; 331(6):482-490. PMID: 38349371
Importance: Repeated mass distribution of azithromycin has been shown to reduce childhood mortality by 14% in sub-Saharan Africa. However, the estimated effect varied by location, suggesting that the intervention may...
6.
Single-dose azithromycin for infant growth in Burkina Faso: Prespecified secondary anthropometric outcomes from a randomized controlled trial
Sie A, Ouattara M, Bountogo M, Dah C, Ouedraogo T, Boudo V, et al.
PLoS Med . 2024 Jan; 21(1):e1004345. PMID: 38261579
Background: Antibiotic use during early infancy has been linked to childhood obesity in high-income countries. We evaluated whether a single oral dose of azithromycin administered during infant-well visits led to...
7.
Azithromycin during Routine Well-Infant Visits to Prevent Death
Sie A, Ouattara M, Bountogo M, Boudo V, Ouedraogo T, Compaore G, et al.
N Engl J Med . 2024 Jan; 390(3):221-229. PMID: 38231623
Background: Mass distribution of azithromycin to children 1 to 59 months of age has been shown to reduce childhood all-cause mortality in some sub-Saharan African regions, with the largest reduction...
8.
The effects of cool roofs on health, environmental, and economic outcomes in rural Africa: study protocol for a community-based cluster randomized controlled trial
Bunker A, Compoare G, Sewe M, Laurent J, Zabre P, Boudo V, et al.
Trials . 2024 Jan; 25(1):59. PMID: 38229177
Background: High ambient air temperatures in Africa pose significant health and behavioral challenges in populations with limited access to cooling adaptations. The built environment can exacerbate heat exposure, making passive...
9.
Assessing the Effect of Extreme Weather on Population Health Using Consumer-Grade Wearables in Rural Burkina Faso: Observational Panel Study
Koch M, Matzke I, Huhn S, Sie A, Boudo V, Compaore G, et al.
JMIR Mhealth Uhealth . 2023 Nov; 11:e46980. PMID: 37938879
Background: Extreme weather, including heat and extreme rainfall, is projected to increase owing to climate change, which can have adverse impacts on human health. In particular, rural populations in sub-Saharan...
10.
Anthropometric Differences in Community- Versus Clinic-Recruited Infants Participating in a Trial of Azithromycin for Prevention of Childhood Mortality in Burkina Faso
Ouattara M, Sie A, Bountogo M, Boudo V, Dah C, Lebas E, et al.
Am J Trop Med Hyg . 2023 Oct; 109(5):1187-1191. PMID: 37783457
Clinic-based recruitment for preventative interventions for child health may select for healthier populations compared with community-based outreach. Nutritional status during infancy as measured by anthropometry is predictive of mortality, growth...